Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa

Transfusion

Volumn 49, Issue 6, 2009, Pages 1115-1125

  Reddy, Ravi ^a   Vermeulen, Marion ^b   Lelie, Nico ^b   Sykes, Wendy ^b   Crookes, Robert ^b   Swanevelder, Johanna ^b   Gaggia, Lilian ^b   Le Roux, Martin ^b   Kuun, Eben ^b   Gulube, Sam ^b  

^a SOUTH AFRICAN NATIONAL BLOOD SERVICE   (South Africa)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN P24; HEPATITIS B SURFACE ANTIGEN;

ARTICLE; BLOOD DONOR; BLOOD TRANSFUSION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ETHNIC DIFFERENCE; FALSE POSITIVE RESULT; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; MAJOR CLINICAL STUDY; SERODIAGNOSIS; SOUTH AFRICA; VIREMIA; VIRUS TRANSMISSION;

BLOOD DONORS; BLOOD TRANSFUSION; DNA, VIRAL; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS C; HIV INFECTIONS; HUMANS; PREVALENCE; RISK; RNA, VIRAL; SOUTH AFRICA;

EID: 66549114612     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2009.02110.x     Document Type: Article

References (24)

1. Heyns A du P, Benjamin RJ, Swanevelder JP, Laycock ME, Pappalardo BL, Crookes RL, Wright DJ, Bush MP. Prevalence of HIV-1 in blood donations following implementation of a structured blood safety policy in South Africa. JAMA 2006 295 : 519 26.
2. Margaritis AR, Brown SM, Seed CR, Kiely P, D'Agostino B, Keller AJ. Comparison of two automated nucleic acid testing systems for simultaneous detection of human immunodeficiency virus and hepatitis C virus RNA and hepatitis B virus DNA. Transfusion 2007 47 : 1783 93.
3. Assal A, Barlet V, Deschaseaux M, Dupont I, Gallian P, Guitton C, Morel P, David B, De Micco P. Comparison of the analytical and operational performance of two automated NAT blood screening systems: Procleix Tigris and cobas s 201. Transfusion. 2008 Nov 4. [Epub ahead of print].
4. Busch MP, Glynn SA, Stramer SL, Strong DM, Caglioti S, Wright DJ, Pappalardo B, Kleinman SH NHLBI-REDS NAT Study Group. A new strategy for estimating risks of transfusion-transmitted viral infections based on rates of detection of recently infected donors. Transfusion 2005 45 : 254 64.
5. Candotti D, Grabarczyk P, Ghiazza P, Roig R, Casamitjana N, Iudicone P, Schmidt M, Bird A, Crookes R, Brojer E. Molecular epidemiology and characterization of occult hepatitis B virus infection (OBI) in European blood donors. J Hepatol 2008 49 : 537 47.
6. Weusten JJ, van Drimmelen HA, Lelie PN. Mathematic modeling of the risk of HBV, HCV, and HIV transmission by window-phase donations not detected by NAT. Transfusion 2002 42 : 537 48.
7. Fiebig EW, Wright DJ, Rawal BD, Garrett PE, Schumacher RT, Peddada L, Heldebrant C, Smith R, Conrad A, Kleinman SH, Busch MP. Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection. AIDS 2003 17 : 1871 9.
8. Glynn SA, Wright DJ, Kleinman SH, Hirschkorn D, Tu Y, Heldebrant C, Smith R, Giachetti C, Gallarda J, Busch MP. Dynamics of viremia in early hepatitis C virus infection. Transfusion 2005 45 : 994 1002. (Pubitemid 40798792)
9. Biswas R, Tabor E, Hsia CC, Wright DJ, Laycock ME, Fiebig EW, Peddada L, Smith R, Schreiber GB, Epstein JS, Nemo GJ, Busch MP. Comparative sensitivity of HBV NATs and HBsAg assays for detection of acute HBV infection. Transfusion 2003 43 : 788 98.
10. Komiya Y, Katayama K, Yugi H, Mizui M, Matsukura H, Tomoguri T, Miyakawa Y, Tabuchi A, Tanaka J, Yoshizawa H. Minimum infectious dose of hepatitis B virus in chimpanzees and difference in the dynamics of viremia between genotype A and genotype C. Transfusion 2008 48 : 286 94.
11. Katayama K, Kumagai J, Komiya Y, Mizui M, Yugi H, Kishimoto S, Yamanaka R, Tamatsukuri S, Tomoguri T, Miyakawa Y, Tanaka J, Yoshizawa H. Titration of hepatitis C virus in chimpanzees for determining the copy number required for transmission. Intervirology 2004 47 : 57 64. (Pubitemid 38420868)
12. Ma M, Piatak M, Fritts L, Lu D, Busch MP, Miller CJ. Transmission of simian immunodeficiency virus (SIV) by plasma collected prior to detectable viremia, and infectivity of ramp up versus chronic stages. Transfusion 2007 Supplement) Abstract S40-030H 17A.
13. Assal A, Barlet V, Deschaseaux M, Dupont I, Gallian P, Guitton C, Morel P, van Drimmelen H, David B, Lelie N, De Micco P. Sensitivity of two HBV/HCV/HIV NAT blood screening systems relative to HBsAg, anti-HCV, anti-HIV and p24/anti-HIV combo assays in seroconversion panels. Transfusion 2009 49 : 301 10.
14. Kleinman SH, Busch MP. Assessing the impact of HBV NAT on window period reduction and residual risk. J Clin Virol 2006 36 (Suppl 1 S23 9.
15. Velati C, Luisa R, lara F, Lorella B, Zanetti AR and the Study Group. Impact of nucleic acid testing for HBV, HCV and HIV on the safety of the blood supply in Italy: a six years survey. Transfusion 2008 48 : 2205 13.
16. Stramer SL, Glynn SA, Klienman SH, Strong DM, Caglioti S, Wright DJ, Dodd RY, Busch MP National Heart, Lung, and Blood Institute Nucleic Acid Test Study Group. Detection of HIV-1 and HCV infections among antibody negative blood donors by nucleic acid amplification testing. N Engl J Med 2004 351 : 760 8.
17. Murthy KK, Henrard DR, Eichberg JW, Cobb KE, Busch MP, Allain JP, Alter HJ. Redefining the HIV window period in the chimpanzee model: evidence to suggest that viral nucleic acid testing can prevent blood-born transmission. Transfusion 1999 39 : 688 93.
18. Busch MP, Operskalski EA, Mosley JW, Lee TH, Henrard D, Herman S, Sachs DH, Harris M, Huang W, Stram DO. Factors influencing human immunodeficiency virus type 1 transmission by blood transfusion. Transfusion Safety Study Group. J Infect Dis 1996 174 : 26 33.
19. Deeks SG, Walker BD. Human immunodeficiency virus controllers: mechanisms of durable virus control in the absence of anti-viral therapy. Immunity 2007 27 : 406 16.
20. Satake M, Taira R, Yugi H, Hino S, Kanemitsu K, Ikeda H, Tadokoro K. Infectivity of blood components with low HBV-DNA levels identified in a look back program. Transfusion 2007 47 : 1197 205.
21. Gerlich WH, Wagner FF, Chudy M, Harritshoj LH, Lattermann A, Wienzek S, Glebe D, Saniewski M, Schuttler CG, Wend UC. HBsAg non reactive HBV infection in blood donors: transmission and pathogenicity. J Med Virol 2007 79 : S32 36.
22. Levicnic-Stenizar S, Rhane-Potokar U, Cadotti D, Lelie N, Allain JP. Anti-HBs positive carrier blood infectious in two transfusion recipients. J Hepatol 2008 48 : 1022 5. Epub 2008 Mar 28.
23. Mphahlele MJ, Lukhwareni A, Burnett RJ, Moropeng LM, Ngobeni JM. High risk of occult hepatitis B virus infection in HIV positive patients from South Africa. J. Clin Virol 2005 35 : 14 20.
24. Tabuchi A, Tanaka J, Katayama K, Mizui M, Matsakura H, Yugi H, Shimada T, Miyakawa Y, Yoshizawa H. Titration of hepatitis B virus infectivity in the sera of pre-acute and late acute phases of HBV infection: transmission experiments to chimera mice with human liver repopulated hepatocytes. J Med Virol 2008 80 : 2064 8.